Production Assistant, Diabetes In Control, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.

Summer Camp Rejuvenation: Hitting the Reset Button

Jul 31, 2018 Disasters Averted, Pediatrics, Type 1 Diabetes 3,322 views

This summer I had the opportunity as a student pharmacist to attend a camp for youth with type 1 diabetes (T1D) and assist as a member of the medical staff. We spent the first few days setting up, going over camp procedures and policies, and preparing for arrival of the campers. This was my first time helping at such an event, and my expectations of how deeply the camp experience would impact the lives of the campers (and myself included!) were greatly exceeded.

Pathophysiology of Type 1 Diabetes Part 2

Jul 31, 2018 Clinical Presentations, Insulin Therapy Center, Type 1 Diabetes 3,886 views

In this week's Homerun Slides, insulin initiation and a comparison of pharmacokinetic and pharmacodynamic insulins.

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #136: Pathogenesis of Type 2 Diabetes Mellitus Part 7

Jul 31, 2018 Clinical Presentations 3,563 views

Cellular mechanisms of insulin resistance: The cellular events via which insulin initiates its stimulatory effect on glucose metabolism start with binding of the hormone to specific receptors that are present on the cell surface of all insulin target tissues. After insulin has bound to and activated its receptor, “second messengers” are generated and these second messengers activate a cascade of phosphorylation-dephosphorylation reactions that result in stimulation of intracellular glucose metabolism. The first step in glucose utilization involves activation of the glucose transport system, leading to glucose influx into insulin target tissues, primarily muscle. The free glucose, which has entered the cell, subsequently is metabolized by a series of enzymatic steps that are under the control of insulin. Of these, the most important are glucose phosphorylation (catalyzed by hexokinase), glycogen synthase (which controls glycogen synthesis), and phosphofructokinase (PFK) and PDH (which regulate glycolysis and glucose oxidation, respectively).

Prediabetes in Adolescence Dramatically Increases Cardiovascular Risk

Jul 28, 2018 Articles, Cardiology, Pediatrics, Prediabetes 9,405 views

Getting diabetes in our later years increases risk for CVD, but getting diabetes or prediabetes as a youth increases risk for CVD and death dramatically.

What Comes First, Diabetes or Cancer?

Jul 28, 2018 Articles, Oncology, Type 2 Diabetes 5,035 views

New study shows that within the first two years of a diagnosis of cancer, the risk for type 2 diabetes increases.

Omnipod Insulin Delivery System Receives FDA Clearance

Jul 28, 2018 Articles, Devices 11,195 views

The Omnipod Dash™ device approved for commercialization and release in the U.S. by mid-2018.

Dual-Hormone Closed-Loop Delivery System Compatible with Exercise

Jul 28, 2018 Articles, Blood Glucose Control, Exercise 4,049 views

Addition of glucagon prevents exercise-induced hypoglycemia.

Is There a Future for BGM?

Jul 28, 2018 Articles, Devices 9,030 views

Guest Post by David Kliff, Editor, Diabetic Investor

With each passing day, it’s becoming more apparent that CGM will replace BGM as the standard for glucose measurement. CGM systems are becoming more patient-friendly, i.e. no calibrations, simple insertion, and cheaper too. The data provided by CGM is transformative, leading to improved outcomes. It is no longer a question of if this will happen but when this will happen.